These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


187 related items for PubMed ID: 29661927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture.
    Giebel AM, Hu S, Rajaram K, Finethy R, Toh E, Brothwell JA, Morrison SG, Suchland RJ, Stein BD, Coers J, Morrison RP, Nelson DE.
    mBio; 2019 Apr 09; 10(2):. PubMed ID: 30967464
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
    Perry LL, Feilzer K, Caldwell HD.
    J Immunol; 1997 Apr 01; 158(7):3344-52. PubMed ID: 9120292
    [Abstract] [Full Text] [Related]

  • 27. CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection.
    Frazer LC, Sullivan JE, Zurenski MA, Mintus M, Tomasak TE, Prantner D, Nagarajan UM, Darville T.
    J Immunol; 2013 Oct 15; 191(8):4269-79. PubMed ID: 24038087
    [Abstract] [Full Text] [Related]

  • 28. [Role of LIGHT signal pathway in Chlamydia muridarum urogenital infection in mice].
    Chen L, Sun Y, Xu S, Fu X, Zhou Z, Lu C, Yang F, Xu G, Wu Y.
    Wei Sheng Wu Xue Bao; 2015 Apr 04; 55(4):492-500. PubMed ID: 26211324
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection.
    Scurlock AM, Frazer LC, Andrews CW, O'Connell CM, Foote IP, Bailey SL, Chandra-Kuntal K, Kolls JK, Darville T.
    Infect Immun; 2011 Mar 04; 79(3):1349-62. PubMed ID: 21149587
    [Abstract] [Full Text] [Related]

  • 34. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
    Yu H, Jiang X, Shen C, Karunakaran KP, Jiang J, Rosin NL, Brunham RC.
    Infect Immun; 2010 May 04; 78(5):2272-82. PubMed ID: 20231405
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E, Verolin M, Stensson A, Lycke N.
    Infect Immun; 2007 Sep 04; 75(9):4638-47. PubMed ID: 17635872
    [Abstract] [Full Text] [Related]

  • 37. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP.
    Infect Immun; 2007 Feb 04; 75(2):666-76. PubMed ID: 17118987
    [Abstract] [Full Text] [Related]

  • 38. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.
    Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O'Meara CP, Timms P, Beagley KW.
    PLoS One; 2013 Feb 04; 8(9):e76664. PubMed ID: 24073293
    [Abstract] [Full Text] [Related]

  • 39. The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses.
    Verma R, Sahu R, Dixit S, Duncan SA, Giambartolomei GH, Singh SR, Dennis VA.
    Front Immunol; 2018 Feb 04; 9():2369. PubMed ID: 30374357
    [Abstract] [Full Text] [Related]

  • 40. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, Andersen P.
    J Infect Dis; 2008 Sep 01; 198(5):758-67. PubMed ID: 18652549
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.